|
Volumn 75, Issue 10, 2004, Pages 1374-1375
|
Intravenous immunoglobulins: A treatment for Alzheimer's disease?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 1 ANTICHYMOTRYPSIN;
AMYLOID BETA PROTEIN ANTIBODY;
AMYLOID BETA PROTEIN[1-42];
AMYLOID PRECURSOR PROTEIN;
CLUSTERIN;
FC RECEPTOR;
IMMUNOGLOBULIN;
PROTEIN ANTIBODY;
SERUM AMYLOID P;
UNCLASSIFIED DRUG;
ACTIVE IMMUNIZATION;
ALZHEIMER DISEASE;
CELL STIMULATION;
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY;
COGNITION;
CYTOKINE PRODUCTION;
EDITORIAL;
HUMAN;
MENINGOENCEPHALITIS;
MICROGLIA;
MULTIPLE SCLEROSIS;
NERVE CELL;
NERVE DEGENERATION;
NEUROTOXICITY;
NONHUMAN;
PASSIVE IMMUNIZATION;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
TREATMENT OUTCOME;
VACCINATION;
ALZHEIMER DISEASE;
AMYLOID BETA-PROTEIN;
ANIMALS;
ANTIBODY FORMATION;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
MICE;
MICE, TRANSGENIC;
VACCINES;
|
EID: 4644337032
PISSN: 00223050
EISSN: None
Source Type: Journal
DOI: 10.1136/jnnp.2004.043141 Document Type: Editorial |
Times cited : (9)
|
References (6)
|